Dose-response models for inhalation of Bacillus anthracis spores: Interspecies comparisons

Risk Analysis

Volumn 28, Issue 4, 2008, Pages 1115-1124

  Bartrand, Timothy A ^a   Weir, Mark H ^a   Haas, Charles N ^a  

^a Drexel University   (United States)

Author keywords

Anthrax; Bacillus anthracis; Bioterrorism; Dose response; Inhalation exposure; Microbial risk assessment

Indexed keywords

AEROSOLS; BACTERIA; BACTERIOLOGY; COST ENGINEERING; MAMMALS; RISK ASSESSMENT; STRAIN;

ANTHRAX; BACILLUS ANTHRACIS; DOSE RESPONSE; INHALATION EXPOSURE; MICROBIAL RISK ASSESSMENT;

BIOTERRORISM;

AEROSOL; BACTERIUM; COMPARATIVE STUDY; DOSE-RESPONSE RELATIONSHIP; MODELING; RISK ASSESSMENT; RODENT; SPORE;

AEROSOL; ANIMAL EXPERIMENT; ARTICLE; BACILLUS ANTHRACIS; BACTERIAL SPORE; BACTERIAL STRAIN; DISPERSION; DOSE RESPONSE; EVALUATION; EXPOSURE; GUINEA PIG; INHALATION; LD 50; NONHUMAN; POISSON DISTRIBUTION; RHESUS MONKEY;

ANIMALIA; BACILLUS ANTHRACIS; CAVIA; MACACA MULATTA;

EID: 48349135422     PISSN: 02724332     EISSN: 15396924     Source Type: Journal    
DOI: 10.1111/j.1539-6924.2008.01067.x     Document Type: Article

References (40)

1. Haas, C. N. (2002). On the risk of mortality to primates exposed to anthrax spores. Risk Analysis, 22 (2 189 193.
2. Glassman, H. N. (1965). Industrial inhalation anthrax. Bacteriological Reviews, 30, 657 659.
3. Defense Intelligence Agency 1986). Soviet Biological Warfare Threat. U.S. Department of Defense, DST-161-OF-057-86, 28.
4. Phipps, A. J., et al. (2004). Rabbit and nonhuman primate models of toxin-targetting human anthrax vaccines. Microbiology and Molecular Biology Reviews, 68 (4 617 629.
5. Peters, C. J., & Hartley, D. M. (2002). Anthrax inhalation and lethal human infection. Lancet, 359, 710 711.
6. Brachman, P. S., Kaufmann, A. F., & Dalldorf, F. G. (1966). Industrial inhalation anthrax. Bacteriological Reviews, 30 (3 646 657.
7. Haas, C. N., Rose, J. B., & Gerba, C. P. (1999). Quantitative Microbial Risk Assessment. New York, John Wiley and Sons.
8. Sharp, R. J., & Roberts, A. G. (2006). Review. Anthrax: The challenge for decontamination. Journal of Chemical Technology and Biotechnology, 81, 1612 1625.
9. Inglesby, T. V., et al. (2002). Anthrax as a biological weapon, 2002. Updated recomendations for management. Journal of American Medical Association, 287 (17 2236 2252.
10. Altboum, Z., et al. (2002). Postexposure prohpylaxis against anthrax: Evaluation of various treatment regimens in intranasally infected guinea Pigs. Infection and Immunity, 70 (1 6231 6241.
11. Druett, H. A., et al. (1953). Studies on respiratory infection. I. The influence of particle size on respiratory infection with anthrax spores. Journal of Hygiene, 51, 359 371.
12. Altboum, Z., et al. (2002). Postexposure prohpylaxis against anthrax: Evaluation of various treatment regimens in intranasally infected guinea pigs. Infection and Immunity, 70 (11 6231 6241.
13. Beedham, R. J., Turnbull, P. C. B., & Williamson, E. D. (2001). Passive transfer of protection against bacillus anthracis infection in a murine model. Vaccine, 19 (31 4409 4416.
14. Jones, W. I., Jr., et al. (1967). Antibiotic treatment of anthrax infection in mice. Journal of Bacteriology, 94 (3 609 614.
15. Little, S. F., & Knudson, G. B. (1986). Comparative efficacy of bacillus anthracis live spore vaccine and protective antigen vaccine against anthrax in the guinea pig. Infection and Immunity, 52 (2 509 512.
16. Nungester, W. J., et al. (1955). Comparative study of host resistance of guinea pigs and rats. i. Virulence of diplococcus pneumoniae and bacillus anthracis for guinea pigs and rats. Journal of Infectious Diseases, 96 (3 227 231.
17. Roth, N. G., DeArmon, I. A., Jr., & Lively, D. H. (1956). Survival time as a rapid method for determining virulence with bacillus anthracis. Journal of Bacteriology, 72 (5 666 672.
18. Tresselt, H. B., & Boor, A. K. (1955). An antigen prepared in vitro effective for immunization against anthrax. Journal of Infectious Diseases, 97 (2 203 206.
19. Welkos, S. L., Keener, T. J., & Gibbs, P. H. (1986). Differences in susceptibility of inbred mice to bacillus anthracis. Infection and Immunity, 51 (3 795 800.
20. Brook, I., et al. (2001). Susceptibility of irradiated mice to bacillus anthracis sterne by the intratracheal route of infection. Journal of Medical Microbiology, 50, 702 711.
21. Kobiler, D., et al. (2002). Efficiency of protection of guinea pigs against infection with bacillus anthracis spores by passive immunization. Infection and Immunity, 70 (2 544 550.
22. Pitt, M. L. M., et al. (2001). In vitro correlate of immunity in a rabbit model of inhalation anthrax. Vaccine, 19, 4768 4773.
23. Vietri, N. J., et al. (2006). Short-course postexposure antibiotic prophylaxis combined with vaccination protects against experimental inhalation anthrax. Proceedings of the National Academy of Sciences, 103 (20 7813 7816.
24. Goldberg, L. J., et al. (1954). Studies on the experimental epidemiology of respiratory infections. Journal of Infectious Diseases, 94 (1 9 21.
25. Vasconcelos, D., et al. (2003). Pathology of inhalation anthrax in cynomolgus monkeys (Macaca fascicularis). Laboratory Investigation, 83 (8 1201 1209.
26. Fellows, P. F., et al. (2001). Efficacy of human anthrax vaccine in guinea pigs, rabbits, and rhesus macaques against challenge by bacillus anthracis isolates of diverse geographical origin. Vaccine, 19 (23-24 3241 3247.
27. Zaucha, G. M., et al. (1998). The pathology of experimental anthrax in rabbits exposed by inhalation and subcutaneous inoculation. Archives of Pathology and Laboratory Medicine, 122 (11 982 992.
28. Moon, H., et al. (2004). A comparison of microbial dose-response models fitted to human data. Regulatory Toxicology and Pharmacology, 40 (2 177 184.
29. Haas, C. N., et al. (1996). Assessing the risk posed by oocysts in drinking water. American Water Works Association Journal, 88 (9 131 136.
30. Armstrong, T. W. (2005). A quantitative microbial risk assessment model for human inhalation exposure to legionella. In Civil, Architectural and Environmental Engineering. Philadelphia, PA : Drexel University.
31. Dowd, S. E., Gerba, C. P., & Pillai, S. D. (2000). Bioaerosol transport modeling and risk assessment in relation to biosolid placement. Journal of Environmental Quality, 29 (1 343 348.
32. Haas, C. N. (1983). Estimation of risk due to low doses of microorganisms: A comparison of alternative methodologies. American Journal of Epidemiology, 118, 573 582.
33. Buchanan, R. L., Smith, J. L., & Long, W. (2000). Microbial risk assessment: Dose-response relations and risk characterization. International Journal of Food Microbiology, 58 (3 159 172.
34. The R Project for Statistical Computing 2006). The R Foundation for Statistical Computing.
35. Morgan, B. J. T. (1992). Analysis of quantal response data. Monographs on Statistics and Applied Probability. London, UK : Chapman and Hall.
36. Shortley, G., & Wilkins, J. R. (1965). Independent-action and birth-death models in experimental microbiology. Bacteriological Reviews, 29 (1 102 141.
37. Day, W. C., & Berendt, R. F. (1972). Experimental Tularemia in Macaca mulatta: Relationship of aerosol particle size to the infectivity of airborne pasteurella tularensis. Infection and Immunity, 5 (1 77 82.
38. Druett, H. A., Henderson, D. A., & Peacock, S. (1953). Studies on respiratory infection. II. Experiments with Brucella suis. Journal of Hygiene, 54 (1 49 57.
39. Druett, H. A., et al. (1956). Studies on respiratory infection. II. The influence of aerosol particle size on infection of the guinea pig with pasteurella pestis. Journal of Hygiene, 54 (1 37 48.
40. Goodlow, R. J., & Leonard, F. A. (1961). Variability and infectivity of microorganisms in experimental airborne infection. Bacteriological Reviews, 25 (3 182 187.